RIAMET 20 mg/120 mg, comprimé

AU:D P01BF01(WHO) AU:S4(Prescription only)US:℞-only 141204-94-6 21106282Y Artemether/lumefantrine, sold under the trade nameCoartemamong others, is a combination of the two medicationsartemetherandlumefantrine.It is used to treatmalariacaused byPlasmodium falciparumthat is not treatable withchloroquine.It is not typically used to prevent malaria.It is taken by mouth. Common side effects include muscle and joint pains, fever, loss of appetite, and headache.Serious side e‍‍‍‍‍‍​​​‍​​​​​​ffects includeprolongation of the QT interval.While not well studied, it appears to be safe for use in pregnancy.The dose does not need changing in those with mild or moderate kidney or liver problems. This combination came into medical use in 1992and was developed in China.It is on theWorld Health Organization's List of Essential Medicines.It is not available as ageneric medication. In July 2025 that Swiss regulatorSwissmedichave approved artemether-lumefantrine, the firstmalariatreatment specifically designed for infants and very young children.The medication is expected to gain rapid regulatory clearance in eight African nations participating in its review.Originally introduced in 1999 for broader malaria treatment, Coartem is now approved in a lower-dose formulation tailored for babies weighing under 4.5 kilograms.The new version dissolves easily—even inbreast milk—and features a cherry flavor to improve ease of use for caregivers.